MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
145.44%
Quick Ratio
133.35%
Cash Ratio
49.90%
Debt to Asset Ratio
88.04%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash
    • Accounts receivable
    • Deferred r&d services, current p...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total current liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
11,198
20,600
30,147
21,097
Accounts receivable
10,939
7,724
5,260
7,047
Collaboration receivable, billed and unbilled
151
89
137
282
Deferred r&d services, current portion (note 10)
2,718
1,374
1,958
1,959
Insurance recovery asset
2,302
-
-
-
Inventory
2,712
1,974
2,236
2,304
Prepaid expenses and other current assets
2,619
2,368
2,801
3,586
Total current assets
32,639
34,129
42,539
36,275
Property and equipment, net
177
191
209
225
Operating lease right-of-use asset
384
463
540
616
Finance lease right-of-use asset
1,473
1,009
1,113
1,050
Deferred r&d services, non-current portion (note 10)
706
2,354
2,354
2,354
Other non-current assets
638
640
376
376
Total assets
36,017
38,786
47,131
40,896
Accounts payable
1,603
2,193
2,072
1,585
Accrued expenses and other current liabilities
14,548
12,251
12,837
12,600
Deferred revenue
1,335
1,031
782
1,564
Current portion of long-term debt
-
-
0
12,458
Legal settlement liability
4,000
-
-
-
Operating lease liability
355
348
341
335
Finance lease liability
601
396
405
366
Total current liabilities
22,442
16,219
16,437
28,908
Operating lease liability
61
152
242
330
Finance lease liability
793
546
643
629
Derivative liability
-
-
0
1,762
R&d funding liability (note 10)
8,414
5,814
5,066
4,688
Long-term debt
-
-
0
21,619
Total liabilities
31,710
22,731
22,388
57,936
Common stock, 0.0001 par value 200,000,000 authorized 17,189,300 shares issued and 17,178,786 shares outstanding as of june 30, 2026 and december 31, 2025
2
2
2
1
Treasury stock, at cost, 10,514 shares as of june 30, 2026 and december 31, 2025
0
0
0
0
Additional paid-in capital
352,053
350,648
349,654
299,798
Accumulated deficit
-347,748
-334,595
-324,913
-316,839
Total stockholders equity
4,307
16,055
24,743
-17,040
Total liabilities and stockholders equity
36,017
38,786
47,131
40,896
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$11,198K (-27.27%↓ Y/Y)Accounts receivable$10,939K (18.99%↑ Y/Y)Deferred r&d services,current portion (note...$2,718K Inventory$2,712K (7.53%↑ Y/Y)Prepaid expenses andother current assets$2,619K (75.54%↑ Y/Y)Insurance recovery asset$2,302K Collaboration receivable,billed and unbilled$151K (-98.15%↓ Y/Y)Total current assets$32,639K (-11.26%↓ Y/Y)Finance leaseright-of-use asset$1,473K (55.87%↑ Y/Y)Deferred r&d services,non-current portion (note...$706K Other non-currentassets$638K (69.68%↑ Y/Y)Operating leaseright-of-use asset$384K (-44.35%↓ Y/Y)Property and equipment,net$177K (-43.81%↓ Y/Y)Total assets$36,017K (-7.90%↓ Y/Y)Total liabilities andstockholders equity$36,017K (-7.90%↓ Y/Y)Total liabilities$31,710K (-43.97%↓ Y/Y)Total stockholdersequity$4,307K (124.63%↑ Y/Y)Accumulated deficit-$347,748K (-9.85%↓ Y/Y)Total currentliabilities$22,442K (-23.20%↓ Y/Y)R&d fundingliability (note 10)$8,414K Finance lease liability$793K (36.96%↑ Y/Y)Operating lease liability$61K (-85.34%↓ Y/Y)Additional paid-in capital$352,053K (17.71%↑ Y/Y)Common stock, 0.0001par value...$2K (100.00%↑ Y/Y)Accrued expenses andother current...$14,548K (11.04%↑ Y/Y)Legal settlementliability$4,000K Accounts payable$1,603K (-30.93%↓ Y/Y)Deferred revenue$1,335K (177.55%↑ Y/Y)Finance lease liability$601K (88.99%↑ Y/Y)Operating lease liability$355K (8.23%↑ Y/Y)

Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Inc. (VRCA)